U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020699

Expand all

EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE)
EQ 37.5MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: EFFEXOR XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 37.5MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020699
Product Number: 001
Approval Date: Oct 20, 1997
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE)
EQ 75MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: EFFEXOR XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020699
Product Number: 002
Approval Date: Oct 20, 1997
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE)
EQ 150MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: EFFEXOR XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020699
Product Number: 004
Approval Date: Oct 20, 1997
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE)
EQ 100MG BASE
Marketing Status: Discontinued
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: EFFEXOR XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020699
Product Number: 003
Approval Date: Oct 20, 1997
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top